FIELD: medicine.
SUBSTANCE: method involves applying phosphodiesterase type 5 inhibitor in combination with Papaverin hydrochloride or Pentoxifilline. Single dose of Sildenafil citrate 10 mg or Tadalafil 3 mg are used as phosphodiesterase type 5 inhibitors. Papaverin hydrochloride is introduced as single dose of 40 mg and Pentoxifilline at a dose of 100 mg.
EFFECT: improved genital blood circulation; reduced risk of adverse side effects.
Authors
Dates
2008-03-10—Published
2006-04-11—Filed